Newronika
Newronika develops adaptive deep brain stimulation systems that respond to the brain's own signals.
$15.88M Series B+ ·
Source: startupintros.com
Funding history ↓Signals
X account@newronika · created Nov 21, 2013 (13 years old) · 90 followers
Website registeredJun 30, 2008 (18 years old)
About Newronika
CE-marked αDBS therapy — precision neuromodulation for Parkinson's and beyond.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $15.88M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
LR
Lorenzo Rossi Co-Founder, CEO & CTOsource: newronika.com- APAlberto Priori Co-Founder, Scientific Advisory Board Chairmansource: newronika.com
- SMSara Marceglia Co-Founder, Associate Professorsource: newronika.com
LK
Lothar Krinke CEO
Investors
EENEA Tech e Biomedical
EEuropean Innovation Council Fund
- FF3F
IIndaco Venture Partners
IInnogest Capital
TTNBT Capital
WWille Finance
Companies like Newronika
AAmber Therapeutics$100M Series A · Jul 2026
RReyedar$3M Seed · Jul 2023- AAlea Health
PPrecision Neuroscience$250M Series B+ · Sep 2026
NNervonik$52.5M Series B+ · Apr 2026
AAmpa HealthSeed · May 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/newronika (get a free API key).